Eton Pharmaceuticals (ETON) Preferred Dividend Payments (2018)

Eton Pharmaceuticals (ETON) posted Preferred Dividend Payments of $22.3 million for Q4 2018, up 2963.37% sequentially from $729000.0 in Q3 2018.

Eton Pharmaceuticals (ETON) Preferred Dividend Payments (2018) Analysis & Trends

Eton Pharmaceuticals has reported Preferred Dividend Payments for 1 years, with the latest figure at $22.3 million in Q4 2018.

Quarterly Preferred Dividend Payments changed N/A year-over-year to $22.3 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $24.5 million (changed N/A YoY) and the FY2018 annual result came in at $24.5 million, up 1551.31% from the prior year.
Preferred Dividend Payments advanced to $22.3 million in Q4 2018 per ETON's latest filing, from $729000.0 in the prior quarter.
Over five years, Preferred Dividend Payments peaked at $22.3 million in Q4 2018 and troughed at $706000.0 in Q1 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Pref Dividends (Qtr)
1	Haleon	43.94 Bn	42.97 Bn	-	-
2	Teva Pharmaceutical Industries	42.95 Bn	39.30 Bn	2.15 Bn	-
3	Zoetis	31.58 Bn	29.90 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn	-
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn	-
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.53 Bn	15.14 Bn	935.80 Mn	-
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.11 Bn	9.95 Bn	-	-
10	Eton Pharmaceuticals	1.70 Bn	1.67 Bn	25.41 Mn	-

Download Data